Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages

Human Reproduction

Volumn 15, Issue 2, 2000, Pages 458-462

  Foka, Z J ^a,c   Lambropoulos, A F ^a   Saravelos, H ^a,b   Karas, G B ^a   Karavida, T ^b   Agorastos, ^b   Zournatzi, P E ^a   Makris, ^a   Bontis, J ^b   Kotsis, A ^a  

^a Hippokration Hospital   (Greece)

^b Hippokration Hospital   (Greece)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Factor V Leiden; Miscarriage; MTHFR C677T mutation; Prothrombin G20210A mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; AUTOANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MUTATION; RECURRENCE RISK; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION;

EID: 0033955432     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.2.458     Document Type: Article

References (30)

1. ACOG (1995) Early pregnancy loss. Int. J. Gynaecol. Obstet., 51, 278-285.
2. Arruda, V.R., von Zuben, P.M., Chiaparini, L.C. et al. (1997) The mutation Ala677-Val in the méthylène tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb. Haemost., 77,818-821.
3. Balasch, J., Reverter, J.C., Fabregues, F. et al. (1997) First-trimester repeated abortion is not associated with activated protein C resistance. Hum. Reprod., 12, 1094-1097.
4. Beauchamp, N.J., Daly, M.E., Hampton, K.K. et al. (1994) High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br. J. Haematol., 88, 219-222.
5. Berry, C.W., Brambati, B., Eskes, T.K. et al. (1995) The Euro-team early pregnancy (ETEP) protocol for recurrent miscarriage. Hum. Reprod., 10, 1516-1520.
6. Bertina, R.M., Koeleman, B.P., Koster, T. et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369, 64-67.
7. Brenner, B. and Blumenfeld, Z. (1997) Thrombophilia and fetal loss. Blood Rev., 11, 72-79.
8. Brenner, B., Mandel, H., Lanir, N. et al. (1997) Activated protein C resistance can be associated with recurrent fetal loss. Br. J. Haematol., 97, 551-554.
9. Brenner, B., Sarig, G., Weiner, Z. et al. (1999) Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb. Haemost., 82, 6-9.
10. Clifford, K., Rai, R., Watson, H. et al. (1994) An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases (see comments). Hum. Reprod., 9, 1328-1332.
11. Dahlback, B., Carlsson, M. and Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc. Natl Acad. Sei. USA, 90, 1004-1008.
12. de Franchis, R., Mancini, P.P., D'Angelo, A. et al. (1996) Elevated total plasma homocy steine and 677C-T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am. J. Hum. Genet., 59, 262-264.
13. Dizon-Townson, D.S., Kinney, S., Branch, D.W. et al. (1997) The factor V Leiden mutation is not a common cause of recurrent miscarriage. J. Reprod. Immunol, 34, 217-223.
14. Frosst, P., Blom, H.J., Milos, R. et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 10, 111-113.
15. Grandone, E., Margaglione, M., Colaizzo, D. et al. (1997) Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb. Haemost., 77, 822-824.
16. Kluijtmans, L.A., den Heijer, M., Reitsma, P.H. et al. (1998) Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb. Haemost., 79, 254-258.
17. Kutteh, W.H., Park, V.M. and Deitcher, S.R. (1998) Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil. Steril., 71, 1048-1053.
18. Lambropoulos, A.F., Foka, Z., Makris, M. el al. (1997) Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2. Blood Coagul. Fibrinolysis, 8, 485-489.
19. Makris, M., Preston, F.E., Beauchamp, N.J. et al. (1997) Co-inheritance of the 202IDA allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb. Haemost., 78, 1426-1429.
20. Margaglione, M., D'Andréa, G., d'Addedda, M. et al. (1998) The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Tliromb. Haemost., 79, 907-911.
21. Pauer, H.U., Neesen, J. and Hinney, B. (1998) Factor V Leiden and its relevance in patients with recurrent abortions. Am. J. Obstet. Gynecol., 178, 629.
22. Poort, S.R., Rosendaal, F.R., Reitsma, PH. et al. (1996) A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
23. Preston, F.E., Rosendaal, F.R., Walker, I.D. et al. (1996) Increased fetal loss in women with heritable thrombophilia. Lancet, 348, 913-916.
24. Rai, R., Regan, L., Hadley, E. et al. (1996) Second-trimester pregnancy loss is associated with activated C resistance. Br. J. Haematol., 92, 489-490.
25. Rees, D.C., Cox, M. and Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133-1134.
26. Regan, L. (1998) Overview of recurrent miscarriage. Gynaecology Forum, 3, 3-7.
27. Ridker, P.M., Miletich, J.P., Buring, J.E. et al. (1998) Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann. Intern. Hed., 128, 1000-1003.
28. Rosendaal, F.R., Doggen, C.J., Zivelin, A. et al. (1998) Geographic distribution of the 20210 G to A prothrombin variant. Tliromb. Haemost., 79, 706-708.
29. Sanson, B.J., Friederich, P.W., Simioni, P. et al. (1996) The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Tliromb. Haemost., 75, 387-388.
30. Wouters, M.G., Boers, G.H., Blom, H.J. etal. (1993) Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil. Steril., 60, 820-825.